Suicide attempt in a dopamine agonist withdrawal syndrome in Parkinson's disease - Espindola M, Rojas NG, Vaisentein G, Da Prat G, Cesarini M, Etcheverry JL, Gatto EM.

Dopamine agonist withdrawal syndrome (DAWS) results from the reduction or suspension of dopamine agonist medications; it encompasses mainly psychiatric symptoms, including suicidal behaviors. In patients with Parkinson's disease (PD), the impact of DAWS ca...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news